Green Cross Medical Science Corporation (KOSDAQ:142280)
3,630.00
+15.00 (0.41%)
Feb 17, 2025, 9:00 AM KST
KOSDAQ:142280 Revenue
Green Cross Medical Science had revenue of 26.92B KRW in the quarter ending September 30, 2024, with 14.58% growth. This brings the company's revenue in the last twelve months to 99.72B, up 1.78% year-over-year. In the year 2023, Green Cross Medical Science had annual revenue of 94.01B, down -16.88%.
Revenue (ttm)
99.72B
Revenue Growth
+1.78%
P/S Ratio
0.80
Revenue / Employee
779.03M
Employees
128
Market Cap
80.32B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 94.01B | -19.10B | -16.88% |
Dec 31, 2022 | 113.11B | 11.43B | 11.25% |
Dec 31, 2021 | 101.67B | -11.70B | -10.32% |
Dec 31, 2020 | 113.38B | 31.88B | 39.13% |
Dec 31, 2019 | 81.49B | -4.83B | -5.59% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 57.73T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,364.39B |
Hyundai Motor Company | 170.28T |
Celltrion | 2,876.25B |
Kia Corporation | 104.63T |
NAVER | 10.39T |